 |
市场调查报告书
商品编码
1983187
生物活性胜肽市场：依原料、治疗领域、通路和地区划分Bioactive Peptide Market, By Source, By Therapeutic Area, By Distribution Channel, By Geography |
||||||
价格
简介目录
预计到2026年，生物活性胜肽市场规模将达到70.896亿美元，到2033年将达到133.28亿美元。预计从2026年到2033年，其复合年增长率将达到9.4%。
| 报告范围 | 报告详情 | ||
|---|---|---|---|
| 基准年： | 2025 | 2026年市场规模： | 7,089,600,000 美元 |
| 历史数据时期： | 2020年至2024年 | 预测期： | 2026年至2033年 |
| 2026年至2033年预测期间的复合年增长率： | 9.40% | 2033年市场规模预测： | 133.28亿美元 |
生物活性胜肽是一类生物分子，通常嵌入母体蛋白质的结构中，并在蛋白质被切割后被活化。另一类胜肽则由许多微生物主动产生和表现。许多生物活性胜肽透过化学或重组技术进行市场推广。生物活性胜肽能够补充蛋白质和其他必需营养素，进而提升食品的营养价值。由于其对健康的许多益处，例如预防和控制心血管疾病、糖尿病、癌症和感染疾病等慢性疾病，生物活性胜肽正日益受到关注。因此，生物活性胜肽也被用于治疗方法大肠激躁症等功能性疾病，预计这将推动市场成长。
市场动态
主要市场参与者活性化对肺水肿和类风湿性关节炎治疗的研发投入，预计将推动全球生物活性胜肽市场在预测期内成长。例如，2022年5月30日，生物技术公司APEPTICO Forschung und Entwicklung GmbH宣布，由APEPTICO主导的国际科学家网络已阐明了索鲁那肽（一种合成肽干粉吸入剂和吸入气雾剂製剂）的3D结构和作用机制，该药物是治疗肺水肿的候选药物。
同样，在2020年成功完成1a期临床试验后，临床阶段生物技术公司Oryn Therapeutics于2021年6月类风湿性关节炎招募患者，进行一项随机、双盲、对照、重复剂量比较的1b期临床试验，受试者为使用DMARD（类风湿性关节炎缓解疾病抗风湿药）治疗的类风湿性关节炎（RA）患者。
本报告的主要特点
- 本报告指出了各个细分市场的潜在商机，并描述了该市场中一系列有吸引力的投资提案。
- 此外，它还提供了有关市场驱动因素和限制因素、机会、新产品发布和核准、市场趋势、区域展望以及主要企业采取的竞争策略的重要见解。
- 本节根据以下参数，介绍全球生物活性胜肽市场中主要企业的概况：公司概况、产品系列、主要亮点、财务表现和策略。
- 本报告中的见解将使负责人和企业经营团队能够就未来的产品发布、产品线更新、市场扩张和行销策略做出明智的决策。
- 《全球生物活性胜肽市场》报告面向该行业的各种相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 相关人员可以透过分析全球生物活性胜肽市场中使用的各种策略矩阵来促进决策。
目录
第一章：分析目标与假设
- 分析目的
- 先决条件
- 简称
第二章 市场展望
- 报告说明
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章：市场动态、监管与趋势分析
- 市场动态
- 促进因素
- 阻碍因素
- 市场机会
- 影响分析
- 主要进展
- 监管趋势
- 救赎方案
- PEST分析
- 新兴市场的未来潜力
第四章：全球生物活性胜肽市场：依来源划分（2026-2033 年）
- 概述
- 植物
- 牛奶
- 蛋
- 肉
- 鱼
- 其他（细菌来源的抗菌肽、毒性肽体学）
第五章：全球生物活性胜肽市场：依治疗领域划分（2026-2033 年）
- 概述
- 抗高血压药物
- 抗氧化剂
- 免疫系统活化
- 抗菌
- 糖尿病
- 其他（消化器官系统和循环系统）
第六章：全球生物活性胜肽市场：依通路划分（2026-2033 年）
- 概述
- 医院药房
- 零售药房
- 网路药房
- 其他（药局、邮购药局）
第七章 全球生物活性胜肽市场：依地区划分（2026-2033年）
- 北美洲
- 我们
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲
- 欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 亚太其他地区
- 中东
- GCC
- 以色列
- 其他中东国家
- 非洲
- 北非
- 中非
- 南非
第八章 竞争情势
- 热图分析
- 公司简介
- Archer Daniels Midland Company
- Seagarden AS
- Phermpep Co. Ltd.
- Arlak Biotech Pvt. Ltd.
- Naturade
- Royal DSM
- MYOS RENS Technology Inc.
- Natural Factors Inc.
- Valio Oy
- GenScript
- HELIX BIOMEDIX
- Oryn Therapeutics
- Selecta Biosciences
- NIBEC
- vivitide
- PEPTIDE INSTITUTE, INC
- BCN Peptides
- Setlance srl.
- APEPTICO Forschung und Entwicklung GmbH
- BIONANOPLUS
第九章
- 参考
- 分析方法
- 关于 Coherent Market Insights
简介目录
Product Code: CMI3018
Bioactive Peptide Market is estimated to be valued at USD 7,089.6 Mn in 2026 and is expected to reach USD 13,328.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 7,089.6 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.40% | 2033 Value Projection: | USD 13,328.0 Mn |
Bioactive peptides are a group of biological molecules that are normally buried in the structure of parent proteins and become active after the cleavage of the proteins. Another group of peptides is actively produced and found in many microorganisms. Many groups of bioactive peptides have been marketed chemically or recombinantly. The bioactive peptides are ingredients that provide nutritive value to the food by adding protein and other important nutrients. Bioactive peptides are gaining popularity, owing to health benefits such as prevention and control of chronic disease conditions like cardiovascular disease, diabetes, cancer, and infectious diseases. Therefore, bioactive peptides are used as treatment therapy for most of the functional disorders such as irritable bowel disease, which is expected to drive the market growth.
Market Dynamics
Increasing research and development by key market players for the treatment of pulmonary edema and rheumatoid arthritis is expected to drive growth of the global bioactive peptide market over the forecast period. For instance, on May 30, 2022, APEPTICO Forschung und Entwicklung GmbH, a biotechnology company, announced that the 3-D structure and the mechanism of action of Solnatide,( a dry powder inhalation and an inhaled aerosol formulation of a synthetic peptide) a possible treatment for pulmonary oedema, had been disclosed by an international network of scientists led by APEPTICO.
Similarly, in June 2021, Oryn Therapeutics, a clinical stage biotechnology company, had opened recruitment for rheumatoid arthritis patients for a Phase 1b clinical trial, which was a Randomized, Double-blind, Vehicle Controlled, and Repeat Dose Comparative Study in RA (rheumatoid arthritis) Patients Managed with DMARDs (Disease-modifying antirheumatic drugs), whereas the Phase 1a clinical trial study had been successfully completed in 2020.
Key features of the study
- This report provides in-depth analysis of the global bioactive peptide market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2022 - 2030, considering 2021 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles key players in the global bioactive peptide market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include, Archer Daniels Midland Company, Seagarden AS, Phermpep Co. Ltd., Arlak Biotech Pvt. Ltd., Naturade, Royal DSM, MYOS RENS Technology Inc., Natural Factors Inc., Valio Oy, GenScript, HELIX BIOMEDIX, Oryn Therapeutics, Selecta Biosciences, NIBEC, vivitide, PEPTIDE INSTITUTE, INC, BCN Peptides, Setlance srl., APEPTICO Forschung und Entwicklung GmbH, and BIONANOPLUS
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global bioactive peptide market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, suppliers, research and consulting firms, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global bioactive peptide market
Market Segmentation
- By Source
- Plant
- Milk
- Egg
- Meat
- Fish
- Others (Bacterial Antimicrobial Peptides, Venom Peptidomics)
- By Therapeutic Area
- Antihypertensive
- Antioxidant
- Immunostimulatory
- Antimicrobial
- Diabetes
- Others (Gastrointestinal System, Cardiovascular System)
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others (Drug Store, Mail-Order Pharmacy)
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Archer Daniels Midland Company
- Seagarden AS
- Phermpep Co. Ltd.
- Arlak Biotech Pvt. Ltd.
- Naturade
- Royal DSM
- MYOS RENS Technology Inc.
- Natural Factors Inc.
- Valio Oy, GenScript
- HELIX BIOMEDIX
- Oryn Therapeutics
- Selecta Biosciences
- NIBEC
- Vivitide
- PEPTIDE INSTITUTE, INC
- BCN Peptides
- Setlance srl.
- APEPTICO Forschung und Entwicklung GmbH
- BIONANOPLUS
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Source
- Market Snapshot, By Therapeutic Area
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Development
- Regulatory Scenario
- Reimbursement Scenario
- Pest Analysis
- Market Potential in Lower economies
4. Global Bioactive Peptide Market, By Source, 2026 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Plant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Milk
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Egg
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Meat
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Fish
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Others (Bacterial Antimicrobial Peptides and Venom Peptidomics)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
5. Global Bioactive Peptide Market, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
- Antihypertensive
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Antioxidant
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Immunostimulatory
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Antimicrobial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Others (Gastrointestinal System and Cardiovascular System)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
6. Global Bioactive Peptide Market, By Distribution Channel, 2026 - 2033, (US$ Million)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
- Others (Drug Store and Mail-Order Pharmacy)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Million)
7. Global Bioactive Peptide Market, By Region, 2026 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Heat Map Analysis
- Company Profile
- Archer Daniels Midland Company
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Seagarden AS
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Phermpep Co. Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Arlak Biotech Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Naturade
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Royal DSM
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- MYOS RENS Technology Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Natural Factors Inc.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Valio Oy
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- GenScript
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- HELIX BIOMEDIX
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Oryn Therapeutics
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Selecta Biosciences
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- NIBEC
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- vivitide
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- PEPTIDE INSTITUTE, INC
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- BCN Peptides
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Setlance srl.
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- APEPTICO Forschung und Entwicklung GmbH
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- BIONANOPLUS
- Company Highlights
- Product Portfolio
- Financial Performance
- Recent Highlights
- Market Strategies
- Analyst Views
9. Section
- References
- Research Methodology
- About Us
02-2729-4219
+886-2-2729-4219
抗体-寡核苷酸复合物市场：按寡核苷酸类型、结合方法、标靶化策略、应用和最终用户划分－全球预测，2026-2030年胜肽杂质市场：依检测分析服务、杂质类型、应用程式和最终用户划分－2026-2032年全球预测环肽市场：按类型、产品类型、技术、应用和最终用户划分，全球预测（2026-2032年）高通量胜肽合成仪市场：按产品类型、技术、应用和最终用户划分 - 全球预测，2026-2032年支链胜肽市场：按应用、胜肽类型、最终用户、技术和分子量划分，全球预测，2026-2032年胜肽杂质分析服务市场（按服务类型、技术、胜肽类型、应用和最终用户划分），全球预测，2026-2032年
下一代药物偶联物市场分析及预测（至2035年）：按类型、产品、技术、应用、最终用户、服务、组件、阶段、部署和製程划分GalNAc-ASO偶联物市场按适应症、给药途径、最终用户和分销管道划分，全球预测，2026-2032年GalNAc-siRNA偶联物市场按产品类型、适应症、製剂、最终用户和分销管道划分，全球预测，2026-2032年GalNAc-siRNA偶联药物市场按适应症、年龄层、应用类型、最终用户和分销管道划分，全球预测，2026-2032年
▼